US Markets

Roche extends offer deadline for Spark Therapeutics again

Credit: REUTERS/ARND WIEGMANN

Roche has again extended the deadline for its tender offer for Spark Therapeutics, the Swiss drugmaker said on Friday, saying U.S. and British anti-trust authorities needed more time to review the deal.

ZURICH, Nov 22 (Reuters) - Roche ROG.S has again extended the deadline for its tender offer for Spark Therapeutics ONCE.O, the Swiss drugmaker said on Friday, saying U.S. and British anti-trust authorities needed more time to review the deal.

The offer, which was originally due to expire on Nov. 25, has now been extended to Dec. 10. All terms and conditions of the offer remain the same, Roche said. So far 14.8% of the shares were tendered.

Roche has put back the deadline several times since it announced the $4.3 billion offer to buy the gene therapy company in February.

(Reporting by John Revill; Editing by Michael Shields)

((John.Revill@thomsonreuters.com; +41 58306 7022; Reuters Messaging: john.revill.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest US Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More